This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Amyotrophic Lateral Sclerosis or Motor Neuron Disease
and you are
between 18 and 75
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

Multicenter, open-label , single and multiple dose-escalation and pharmacokinetic study

Provided treatments

  • Drug: Cu(II)ATSM

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02870634. The sponsor of the trial is Collaborative Medicinal Development Pty Limited and it is looking for 50 volunteers for the current phase.
Official trial title:
A Phase 1 Single and Multiple Dose Escalation and Pharmacokinetic Study of Cu(II)ATSM Administered Orally to Patients With Amyotrophic Lateral Sclerosis/Motor Neuron Disease